The Announcement
On Tuesday, October 13, 2026, Nvidia agreed to buy minority stakes in two French technology companies: Doctolib, the healthcare appointment-scheduling platform, and Genesis AI, a robotics and artificial intelligence startup. The announcements were made in Paris, where Nvidia CEO Jensen Huang was visiting.
Doctolib said Nvidia had agreed to buy a minority stake without specifying the size of the stake or its value, adding that Nvidia's involvement would help it develop artificial intelligence tools. Genesis AI confirmed the news following an earlier report by French business newspaper Les Echos, stating: "We are excited that Nvidia is a strategic investor in Genesis AI."
Les Echos also reported that Nvidia bought stakes in two more French companies — Entalpic, which applies generative AI to materials discovery, and Pigment, an AI-powered business planning software firm. Neither Entalpic nor Pigment had confirmed the reports at the time. According to additional coverage, the four stakes span four very different industries: healthcare scheduling, general-purpose robotics, materials science, and financial planning software — suggesting Nvidia is seeding AI adoption across verticals where its chips and software stack can become the default infrastructure layer.
Who Are Doctolib and Genesis AI?
Doctolib is one of France's most prominent tech companies. Founded in Paris, it operates a platform that lets patients book medical appointments online and gives healthcare professionals tools for managing their practices and patient relationships. It has grown well beyond simple scheduling into a broader healthcare platform, and is now expanding into AI-powered tools for healthcare professionals — the area where Nvidia's involvement is expected to matter most, with Nvidia committing to help Doctolib train AI models.
Genesis AI is a robotics and AI startup working on general-purpose robotic systems. The name reflects the current wave of "foundation model for robotics" startups — companies attempting to build generalized AI that can control robots across many tasks, rather than machines programmed for a single function. Nvidia has been investing heavily in this thesis through its Cosmos world models and robotics simulation platforms, making Genesis AI a natural fit for its portfolio.
Nvidia's Broader European Strategy
The French deals do not stand alone. They follow Nvidia's earlier financing arrangement tied to Mistral AI, the French foundation-model company: Nvidia participated in a debt financing structure connected to Mistral's Paris data center and the supply of Nvidia GPUs for it. The pattern is consistent: Nvidia combines equity stakes with infrastructure financing to lock in long-term relationships with European AI companies.
Additional reporting around the Paris announcements suggested Nvidia was expected to unveil further European investments, framing the effort as driving the "AI revolution in Europe" with an emphasis on open-source AI models tailored to European languages and data sovereignty — themes that resonate with EU policymakers who have pushed for the continent to reduce its dependence on non-European AI infrastructure.
Why Europe Is Strategic Ground
The contrast with Nvidia's position in China is instructive. Reports have put Nvidia's share of China's AI chip market at roughly 34%, with Huawei climbing toward 28% as domestic alternatives gain ground and export restrictions bite. In Europe, Nvidia faces no equivalent domestic chip rival at Huawei's scale. That structural advantage lets Nvidia play offense — expanding through equity relationships, developer ecosystems, and infrastructure partnerships — rather than fighting a defensive chip-sales battle against a competitor.
Europe is also where AI adoption by enterprises is still relatively early. A relatively small equity check in a company like Doctolib buys Nvidia meaningful influence over how a major platform builds its AI products — which almost certainly means those products get built on Nvidia's hardware and software stack. It is a cheap form of vertical integration: instead of acquiring customers through sales, Nvidia co-owns the companies that will buy its GPUs.
What This Means for Investors and Founders
Nvidia's corporate venturing playbook has become one of the most consequential forces in AI startup funding. Its investments do two things at once: they provide validation that unlocks further fundraising for the startup, and they guarantee Nvidia a customer relationship as the company scales its compute needs.
For European founders, the signal is clear: Nvidia is actively shopping for stakes in companies that are building AI-native products in high-value verticals — healthcare, robotics, enterprise software, and scientific computing. The common thread is not the industry but the compute appetite: each of these companies will need enormous amounts of GPU power to realize its roadmap, and Nvidia is happy to be both an investor and the supplier.
For investors, the deals reinforce that AI infrastructure is no longer just a hardware story. The value is migrating up the stack into the platforms and applications that run on the infrastructure — and Nvidia is using its balance sheet to make sure it owns a piece of that migration. Angeled.com connects founders with investors.
Read Next
Decoupling Reaches Seed VC: The MiraclePlus Sanctions and What They Mean
Nauta Closes €60M First Close for Fund VI to Back European B2B Software
Fusion Energy: An Investor's Guide to the Road to the Grid
Solid-State Batteries: The Commercialization Timeline Investors Should Actually Watch
The Virtual Power Plant Wave: Why Energy Just Became a Top VC Category
Where India's Consumer and Fintech VC Is Betting in Late 2026




